David Epstein, MD, MBA, an independent consultant, gives an overview of payer considerations surrounding vitiligo. Jeffrey D. Dunn, PharmD, MBA: Let me go down that path a little further and bring Dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback